ASCO 2022 Conference Coverage

 

ASCO 2022 Conference Coverage
A

ASCO 2022 IMMUNIB Trial: A Single-Arm, Phase II Study Evaluating Safety & Efficacy of Nivo in Combination With Lenvatinib in Advanced Stage HCC

By ASCO 2022 Conference Coverage FEATURING Arndt Vogel
By ASCO 2022 Conference Coverage FEATURING Arndt Vogel
341 views
June 15, 2022
Comments 0
Login to view comments. Click here to Login

Featured Video

03:15
Lilly Medical Affairs

Unmet Needs and Resistance Mechanisms in Patients With HR+, HER2- MB…

Feat. W. Mchayleh

Featured Video

03:38
Lilly Medical Affairs

SERDS: Relevance and Role in Current & Future Treatments for HR+…

Feat. K. Jhaveri
GI
10:11

ASCO 2022 on Atezolizumab + Bevacizumab vs Lenvatinib or Sorafenib i…

ASCO 2022 Conference Coverage

M. Rimini

278 views
07:56

ASCO 2022 on RAS Co-Mutation and Early Onset Disease Represent an Ag…

ASCO 2022 Conference Coverage

B. Johnson

97 views
03:33

ASCO 2022 Patient-Reported Outcomes From the Phase 3 HIMALAYA Study …

ASCO 2022 Conference Coverage

P. Galle

73 views
02:15

Lecture Summary - ASCO 2022 Adjuvant Chemotherapy Guided by ctDNA An…

ASCO 2022 Conference Coverage

J. Tie

18 views
07:51

Updates on the PARADIGM Trial: PAN + mFOLFOX6 vs. BEV + mFOLFOX6 as …

ASCO 2022 Conference Coverage

T. Yoshino

161 views
01:21

Lecture Summary - ASCO 2022 on Phase 3 CAIRO5 Study: FOLFOXIRI + Bev…

ASCO 2022 Conference Coverage

C. Punt

20 views
07:57

ASCO 2022 on Phase I/II Trial of Encorafenib, Cetuximab, & Nivolumab…

ASCO 2022 Conference Coverage

V. Morris

342 views
59

Lecture Summary - ASCO 2022 on Phase I/II Trial of Encorafenib, Cetu…

ASCO 2022 Conference Coverage

V. Morris

14 views
07:35

ASCO 2022 on an Open-Label, Multicenter, Randomized Phase II Study o…

ASCO 2022 Conference Coverage

A. Ruth He, F. Banovac

238 views
40

Lecture Summary - ASCO 2022 on an Open-Label, Multicenter, Randomize…

ASCO 2022 Conference Coverage

A. Ruth He, F. Banovac

15 views
58

Lecture Summary - ASCO 2022 on EA2183: A Phase III Study of Consolid…

ASCO 2022 Conference Coverage

N. Uboha

229 views
06:44

ASCO 2022 on EA2183: A Phase III Study of Consolidative RT in Patien…

ASCO 2022 Conference Coverage

N. Uboha

511 views
05:40

ASCO 2022 Phase 2 Study of Trastuzumab Deruxtecan in the Neoadjuvant…

ASCO 2022 Conference Coverage

D. Takahari

130 views
11:07

ASCO 2022 The Differential Response to Immune Checkpoint Inhibitors …

ASCO 2022 Conference Coverage

M. Khushman

88 views
06:33

ASCO 2022 Testing of a Machine Learning Model for Ability to Predict…

ASCO 2022 Conference Coverage

M. Sun

11 views
05:53

ASCO 2022 on a Regional Subgroup Analysis of the Phase 3 TOPAZ-1 Stu…

ASCO 2022 Conference Coverage

A. Vogel

153 views
04:54

ASCO 2022 IMMUTACE - A Biomarker-Orientated Phase II, Single-Arm, Op…

ASCO 2022 Conference Coverage

A. Vogel

96 views
05:30

ASCO 2022 on SWOG S2012: Randomized Phase II/III Trial of 1L Platinu…

ASCO 2022 Conference Coverage

D. Zhen

9 views
05:12

ASCO 2022 IMMUNIB Trial: A Single-Arm, Phase II Study Evaluating Saf…

ASCO 2022 Conference Coverage

A. Vogel

341 views
10:29

ASCO 2022 Using cfDNA to Identify Guideline-Relevant Biomarkers for …

ASCO 2022 Conference Coverage

P. Kasi

219 views
58

Lecture Summary - ASCO 2022 Targeting HER2 Mutation-Positive Advance…

ASCO 2022 Conference Coverage

J. Harding

16 views
54

Lecture Summary - ASCO 2022 on ctDNA Profile in Pancreatic Ductal Ad…

ASCO 2022 Conference Coverage

F. Esposito

17 views
09:42

ASCO 2022 Targeting HER2 Mutation-Positive Advanced Biliary Tract Ca…

ASCO 2022 Conference Coverage

J. Harding

91 views
05:39

ASCO 2022 on ctDNA Profile in Pancreatic Ductal Adenocarcinoma and P…

ASCO 2022 Conference Coverage

F. Esposito

885 views
04:22

ASCO 2022 on the Multicenter Phase Ib US Trial of Salvage CT041 CLDN…

ASCO 2022 Conference Coverage

G. Botta

140 views
01:26

Lecture Summary - ASCO 2022 on the Multicenter Phase Ib US Trial of …

ASCO 2022 Conference Coverage

G. Botta

26 views
01:13

Lecture Summary - ASCO 2022 on Investigating a Switch Maintenance Co…

ASCO 2022 Conference Coverage

S. Stintzing

24 views
55

Lecture Summary - ASCO 2022 on Perioperative Ramucirumab + FLOT vs. …

ASCO 2022 Conference Coverage

T. Oliver Götze

17 views
07:37

ASCO 2022 on Investigating a Switch Maintenance Concept With 5-FU + …

ASCO 2022 Conference Coverage

S. Stintzing

204 views
08:49

ASCO 2022 on the Phase 2/3 Study of an Individualized Neoantigen Vac…

ASCO 2022 Conference Coverage

J. Hecht

155 views
34

Lecture Summary - ASCO 2022 on the Phase 2/3 Study of an Individuali…

ASCO 2022 Conference Coverage

J. Hecht

53 views
06:16

ASCO 2022 on NSABP FC-10: A Phase Ib Study of Pembro + Pemetrexed & …

ASCO 2022 Conference Coverage

J. Krauss

73 views
34

Lecture Summary - ASCO 2022 on mFOLFOXIRI + PAN vs. mFOLFOX6/PAN as …

ASCO 2022 Conference Coverage

C. Cremolini

44 views
11:34

ASCO 2022 on mFOLFOXIRI + PAN vs. mFOLFOX6/PAN as Initial Treatment …

ASCO 2022 Conference Coverage

C. Cremolini

191 views
09:20

ASCO 2022 on the Comparative Efficacy of Novel Combination IO Strate…

ASCO 2022 Conference Coverage

C. Fulgenzi

219 views
40

Lecture Summary - ASCO 2022 on Multicenter Phase II Study of Abemaci…

ASCO 2022 Conference Coverage

R. Kelly

18 views
05:15

ASCO 2022 on Multicenter Phase II Study of Abemaciclib & Ramucirumab…

ASCO 2022 Conference Coverage

R. Kelly

234 views
31

Lecture Summary - ASCO 2022 NEOPRISM CRC: Neoadjuvant Pembrolizumab …

ASCO 2022 Conference Coverage

K. Shiu

36 views
15:40

ASCO 2022 NEOPRISM CRC: Neoadjuvant Pembrolizumab Stratified to Tumo…

ASCO 2022 Conference Coverage

K. Shiu

1.1K views
01:02

Lecture Summary - ASCO 2022 on Pembrolizumab + mFOLFOX7/FOLFIRI for …

ASCO 2022 Conference Coverage

R. Kim

358 views
08:41

ASCO 2022 on KEYNOTE-651: Pembrolizumab + mFOLFOX7/FOLFIRI for mCRC:…

ASCO 2022 Conference Coverage

R. Kim

2.3K views
43

Lecture Summary - ASCO 2022 on CRC Metastatic dMMR Immuno-Therapy (C…

ASCO 2022 Conference Coverage

M. Overman

19 views
04:11

ASCO 2022 on CRC Metastatic dMMR Immuno-Therapy (COMMIT) Phase 3 Stu…

ASCO 2022 Conference Coverage

M. Overman

1.1K views
39

Lecture Summary - ASCO 2022 Immunotherapy With Nivolumab After Progr…

ASCO 2022 Conference Coverage

A. Rauthan

117 views
09:02

ASCO 2022 Immunotherapy With Nivolumab After Progression on Lenvatin…

ASCO 2022 Conference Coverage

A. Rauthan

235 views
23

Lecture Summary - ASCO 2022 Updates on Infigratinib vs. Gemcitabine …

ASCO 2022 Conference Coverage

G. Abou-Alfa

104 views
06:42

ASCO 2022 on PROOF 301 Trial: Updates on Infigratinib vs. Gemcitabin…

ASCO 2022 Conference Coverage

G. Abou-Alfa

1.1K views